Total Funding
71
42
Total FundingSeries A raised
Growth Score
-8 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
36502
EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles.
- Jeanne Volatron: CEO and Co-founder
About the Company
EVerZom is a nanomedicine biotech company providing a large scale of GMP manufacturing platform of extracellular vesicles. They develop a bioproduction platform to produce extracellular vesicles at a commercial scale in a GMP compliant way for pharmaceutical companies with applications in regenerative medicine and drug delivery. Extracellular
vesicles that encompass exosomes, microvesicles, and apoptotic bodies are the tools used by cells to communicate with each other.
EVerZom was founded in 2019 and is headquartered in Paris, Ile-de-France, France.
